Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Importance Several factors are associated with increased hepatocellular carcinoma (HCC)
recurrence after liver transplantation (LT), but no reliable risk score has been established to …

The selection of liver transplant candidates with hepatocellular carcinoma (HCC) relies
mostly on tumor size and number. Instead of relying on these factors, we used poor tumor …

Recent years have seen significant progress in the systemic treatment of hepatocellular
carcinoma (HCC), including the advent of immunotherapy. While several large phase III …

Objective: To evaluate predictors of mortality and impact of treatment in patients developing
recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT). Summary of …

AIM: To investigate the efficacy (survival) and safety of treatments for recurrent
hepatocellular carcinoma (HCC) in liver transplantation (LT) patients. METHODS: Literature …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Liver transplantation is the best treatment option for cirrhotic patients with early-stage
hepatocellular carcinoma, but it faces the problem of scarcity of donors and the risk of tumor …

Background and purpose Tumor recurrence after liver transplantation (LT) impedes the
curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a …